This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tsuchiya, H. Articles by Hino, O. Search for Related Content PubMed PubMed Citation Articles by Tsuchiya, H. Articles by Hino, O.

Presence of Potent Transcriptional Activation Domains in the Predisposing Tuberous Sclerosis (Tsc2) Gene Product of the Eker Rat Model¹

Department of Experimental Pathology, Cancer Institute, 1-37-1 Kami-Ikebukuro, Toshima-ku, Tokyo 170, Japan

The Eker rat hereditary renal carcinoma is an excellent example of a Mendelian dominant predisposition to a specific cancer in an experimental animal. We recently reported that a germline insertion in the rat homologue of the human tuberous sclerosis gene (TSC2) gives rise to dominantly inherited cancer in the Eker rat model, as well as a tumor suppressor nature for the Tsc2 gene function. We also showed a strong conservation between the rat and human gene products. The molecular function of the Tsc2 gene product (called "tuberin" in the human case) is not yet understood, although it contains a short amino acid sequence homologous to ras family GTPase-activating proteins (Rap1GAP). Here, we describe transcriptional activation domains (AD1 and AD2) in the carboxyl terminus of the Tsc2 product (in exons 30 and 32 and exon 41, respectively). The Eker insertional mutation (intron 30) disrupts their transcriptional activity. Whereas a COOH-terminal truncated Tsc2 protein was localized in the nucleus, the full-length protein is found predominantly in the perinuclear region of cytoplasm. The present demonstration of transcriptional activation domains in the Tsc2 gene provides clues for studying its role in renal carcinogenesis.

¹ This work was supported in part by Grants-in-Aid for Cancer Research from the Ministry of Education, Science and Culture of Japan and the Council for Tobacco Research.

² To whom requests for reprints should be addressed. Phone/Fax: 81-3-5394-3815.

Received 11/27/95. Accepted 12/12/95.

This article has been cited by other articles:

				D. Clements, R. J. Mayer, and S. R. Johnson Subcellular distribution of the TSC2 gene product tuberin in human airway smooth muscle cells is driven by multiple localization sequences and is cell-cycle dependent Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L258 - L266. [Abstract] [Full Text] [PDF]

				Y. Cao, Y. Kamioka, N. Yokoi, T. Kobayashi, O. Hino, M. Onodera, N. Mochizuki, and J. Nakae Interaction of FoxO1 and TSC2 Induces Insulin Resistance through Activation of the Mammalian Target of Rapamycin/p70 S6K Pathway J. Biol. Chem., December 29, 2006; 281(52): 40242 - 40251. [Abstract] [Full Text] [PDF]

				T. M. Kolb, L. Duan, and M. A. Davis Tsc2 Expression Increases the Susceptibility of Renal Tumor Cells to Apoptosis Toxicol. Sci., December 1, 2005; 88(2): 331 - 339. [Abstract] [Full Text] [PDF]

				K.-S. Au, A. T. Williams, M. J. Gambello, and H. Northrup Molecular Genetic Basis of Tuberous Sclerosis Complex: From Bench to Bedside J Child Neurol, September 1, 2004; 19(9): 699 - 709. [Abstract] [PDF]

				F. G. Garaci, R. Floris, A. Bozzao, G. Manenti, A. Simonetti, T. Lupattelli, P. Curatolo, and G. Simonetti Increased Brain Apparent Diffusion Coefficient in Tuberous Sclerosis Radiology, August 1, 2004; 232(2): 461 - 465. [Abstract] [Full Text] [PDF]

				M. C. Birchenall-Roberts, T. Fu, O.-s. Bang, M. Dambach, J. H. Resau, C. L. Sadowski, D. C. Bertolette, H.-J. Lee, S.-J. Kim, and F. W. Ruscetti Tuberous Sclerosis Complex 2 Gene Product Interacts with Human SMAD Proteins: A MOLECULAR LINK OF TWO TUMOR SUPPRESSOR PATHWAYS J. Biol. Chem., June 11, 2004; 279(24): 25605 - 25613. [Abstract] [Full Text] [PDF]

				K Mayer, M Goedbloed, K van Zijl, M Nellist, and H-D Rott Characterisation of a novel TSC2 missense mutation in the GAP related domain associated with minimal clinical manifestations of tuberous sclerosis J. Med. Genet., May 1, 2004; 41(5): e64 - e64. [Full Text] [PDF]

				H.-S. Yoon, S. Ramachandiran, M. A. S. Chacko, T. J. Monks, and S. S. Lau Tuberous sclerosis-2 tumor suppressor modulates ERK and B-Raf activity in transformed renal epithelial cells Am J Physiol Renal Physiol, February 1, 2004; 286(2): F417 - F424. [Abstract] [Full Text] [PDF]

				V. P. Krymskaya and J. M. Shipley Lymphangioleiomyomatosis: A Complex Tale of Serum Response Factor-Mediated Tissue Inhibitor of Metalloproteinase-3 Regulation Am. J. Respir. Cell Mol. Biol., May 1, 2003; 28(5): 546 - 550. [Full Text] [PDF]

				S. Momose, T. Kobayashi, H. Mitani, M. Hirabayashi, K. Ito, M. Ueda, Y.-i. Nabeshima, and O. Hino Identification of the coding sequences responsible for Tsc2-mediated tumor suppression using a transgenic rat system Hum. Mol. Genet., November 15, 2002; 11(24): 2997 - 3006. [Abstract] [Full Text] [PDF]

				K. S. Mcdorman and D. C. Wolf Use of the Spontaneous Tsc2 Knockout (Eker) Rat Model of Hereditary Renal Cell Carcinoma for the Study of Renal Carcinogens Toxicol Pathol, October 1, 2002; 30(6): 675 - 680. [Abstract] [PDF]

				E. A. Goncharova, D. A. Goncharov, A. Eszterhas, D. S. Hunter, M. K. Glassberg, R. S. Yeung, C. L. Walker, D. Noonan, D. J. Kwiatkowski, M. M. Chou, et al. Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation. A ROLE FOR THE TSC2 TUMOR SUPPRESSOR GENE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS (LAM) J. Biol. Chem., August 16, 2002; 277(34): 30958 - 30967. [Abstract] [Full Text] [PDF]

				D. J. Kwiatkowski, H. Zhang, J. L. Bandura, K. M. Heiberger, M. Glogauer, N. el-Hashemite, and H. Onda A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells Hum. Mol. Genet., March 1, 2002; 11(5): 525 - 534. [Abstract] [Full Text] [PDF]

				A. Miloloza, M. Rosner, M. Nellist, D. Halley, G. Bernaschek, and M. Hengstschlager The TSC1 gene product, hamartin, negatively regulates cell proliferation Hum. Mol. Genet., July 22, 2000; 9(12): 1721 - 1727. [Abstract] [Full Text] [PDF]

				M. Nellist, M. A. van Slegtenhorst, M. Goedbloed, A. M. W. van den Ouweland, D. J. J. Halley, and P. van der Sluijs Characterization of the Cytosolic Tuberin-Hamartin Complex. TUBERIN IS A CYTOSOLIC CHAPERONE FOR HAMARTIN J. Biol. Chem., December 10, 1999; 274(50): 35647 - 35652. [Abstract] [Full Text] [PDF]

				T. Kobayashi, O. Minowa, J. Kuno, H. Mitani, O. Hino, and T. Noda Renal Carcinogenesis, Hepatic Hemangiomatosis, and Embryonic Lethality Caused by a Germ-Line Tsc2 Mutation in Mice Cancer Res., March 1, 1999; 59(6): 1206 - 1211. [Abstract] [Full Text] [PDF]

				N. Satake, T. Kobayashi, E. Kobayashi, K. Izumi, and O. Hino Isolation and Characterization of a Rat Homologue of the Human Tuberous Sclerosis 1 Gene (Tsc1) and Analysis of Its Mutations in RatRenal Carcinomas Cancer Res., February 1, 1999; 59(4): 849 - 855. [Abstract] [Full Text] [PDF]

				K. W. Henry, X. Yuan, N. J. Koszewski, H. Onda, D. J. Kwiatkowski, and D. J. Noonan Tuberous Sclerosis Gene 2 Product Modulates Transcription Mediated by Steroid Hormone Receptor Family Members J. Biol. Chem., August 7, 1998; 273(32): 20535 - 20539. [Abstract] [Full Text] [PDF]

				T. Kobayashi, H. Mitani, R.-i. Takahashi, M. Hirabayashi, M. Ueda, H. Tamura, and O. Hino Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild-type Tsc2 gene PNAS, April 15, 1997; 94(8): 3990 - 3993. [Abstract] [Full Text] [PDF]